PDCD1 and neoplasm: These data suggest that blocking PD-L1–mediated T cell inactivation by either anti–PD-1 antibody and/or HITT increases the survival of mammary tumor–bearing mice by suppressing tumor growth with low toxicity (Figure 9E).